Skip to main content

and
  1. No Access

    Article

    Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer

    To investigate if delta-radiomics features have the potential to predict the major pathological response (MPR) to neoadjuvant chemoimmunotherapy in non-small cell lung cancer (NSCLC) patients.

    **aoyu Han, Mingliang Wang, Yuting Zheng, Na Wang, Ying Wu in European Radiology (2024)